ArticlePloS one2014

A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy.

Seung Jun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.